These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
363 related items for PubMed ID: 1825799
21. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study. Goh KT, Tan KL, Kong KH, Oon CJ, Chan SH. Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584 [Abstract] [Full Text] [Related]
22. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study]. Lyu JJ, Zhang L, Yan BY, Liu JY, Feng Y, Song LZ, Chen SY, Zhou LB, Liang XF, Cui FQ, Wang FZ, Xu AQ. Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725 [Abstract] [Full Text] [Related]
23. Progress in vaccination against hepatitis B in the Americas. Ropero AM, Danovaro-Holliday MC, Andrus JK. J Clin Virol; 2005 Dec; 34 Suppl 2():S14-9. PubMed ID: 16461235 [Abstract] [Full Text] [Related]
24. Vaccination against hepatitis B: comparison of three different vaccination schedules. Jilg W, Schmidt M, Deinhardt F. J Infect Dis; 1989 Nov; 160(5):766-9. PubMed ID: 2530289 [Abstract] [Full Text] [Related]
25. Clinical trial of hepatitis B vaccine in a simplified immunization programme. Coursaget P, Yvonnet B, Sarr M, Vincelot P, Tortey E, Mboup S, Chiron JP, Diop-Mar I. Bull World Health Organ; 1986 Nov; 64(6):867-71. PubMed ID: 2951032 [Abstract] [Full Text] [Related]
29. A modified immunisation schedule for the hepatitis B vaccine Recombivax HB suitable for mass vaccination in childhood. Piazza M, Abrescia N, Picciotto L, Cotugno M, Vegnente A, Iorio R, Cimmino L. Boll Soc Ital Biol Sper; 1991 Feb; 67(2):207-11. PubMed ID: 1832284 [Abstract] [Full Text] [Related]
30. One year evaluation of immunogenicity conferred by a Chinese hamster ovary cell recombinant hepatitis B vaccine in a French Polynesian newborn immunization programme. Spiegel A, Boutin JP, Cartel JL, Chanteau S, Cardines R, Saliou P, Roux JF. Trans R Soc Trop Med Hyg; 1991 Feb; 85(6):783-7. PubMed ID: 1801354 [Abstract] [Full Text] [Related]
34. Prevention of hepatitis B infection in newborns through mass screening and delayed vaccination of all infants of mothers with hepatitis B surface antigen. Schalm SW, Mazel JA, de Gast GC, Heijtink RA, Botman MJ, Bänffer JR, Cerards LJ, Zwijnenberg J, Fetter WP, Nuijten SM. Pediatrics; 1989 Jun; 83(6):1041-8. PubMed ID: 2726331 [Abstract] [Full Text] [Related]
35. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada. Huynh C, Minuk GY, Uhanova J, Baikie M, Wong T, Osiowy C. Vaccine; 2017 Aug 16; 35(35 Pt B):4515-4522. PubMed ID: 28736196 [Abstract] [Full Text] [Related]
38. Investigating hepatitis B immunity in patients presenting to a paediatric haematology and oncology unit in South Africa. Büchner A, Omar FE, Vermeulen J, Reynders DT. S Afr Med J; 2014 Jun 19; 104(9):628-31. PubMed ID: 25212405 [Abstract] [Full Text] [Related]
40. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen. Frazer IH, Jones B, Dimitrakakis M, Mackay IR. Med J Aust; 1987 Mar 02; 146(5):242-5. PubMed ID: 2950303 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]